Want to stay updated on the latest news?
Create a Reader Account today to follow the industries and companies that interest you, and customize your news dashboard. SIGN INTO READER ACCOUNT CREATE READER ACCOUNT
LeddarTech Releases Its LeddarSteer Automotive-Grade, Solid-State Digital Beam Steering Technology for LiDAR Sensor Developers
May 10, 2022 00:07 ET
|
LeddarTech inc.
QUEBEC, May 10, 2022 (GLOBE NEWSWIRE) -- LeddarTech®, a global leader in providing the most flexible, robust and accurate ADAS and AD sensing technology, is pleased to announce the official release...
LeddarTech lance LeddarSteer, la technologie solid-state d’orientation numérique du faisceau de classe automobile pour les développeurs de capteurs LiDAR
May 10, 2022 00:07 ET
|
LeddarTech inc.
QUÉBEC, 10 mai 2022 (GLOBE NEWSWIRE) -- LeddarTech®, chef de file de calibre mondial en technologie de détection précise, robuste et polyvalente pour les systèmes avancés d’aide à la conduite...
Deep Brain Stimulation Devices Market to Exhibit a CAGR of 11.6% by 2026; Rising Geriatric Population to Enable Expansion, states Fortune Business Insights™
June 19, 2020 10:14 ET
|
Fortune Business Insights
Pune, June 19, 2020 (GLOBE NEWSWIRE) -- The global deep brain stimulation devices market size is expected to reach USD 1,676.8 million by 2026, exhibiting a CAGR of 11.6% during the forecast...
Deep Brain Stimulation for Treatment-Resistant Depression: A Progress Report - A Free Webinar from the Brain & Behavior Research Foundation
September 18, 2019 09:00 ET
|
Brain & Behavior Research Foundation
New York, Sept. 18, 2019 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation is hosting a free interactive webinar on “Deep Brain Stimulation for Treatment-Resistant Depression: A...
Rising Prevalence of Neurological Diseases Driving the Neuromodulation Devices Market Growth; to Witness a CAGR of 10.3% during 2019-2025
June 04, 2019 09:23 ET
|
Energias Market Research
NEW YORK, June 04, 2019 (GLOBE NEWSWIRE) -- The global neuromodulation devices market is expected to grow significantly from USD 5,120 Million in 2018 to USD 10,200 Million in 2025, at a CAGR of...
Adamas Announces Publication of Amantadine Immediate Release Subgroup Analysis From EASE LID 2 Open-label Study in Movement Disorders Clinical Practice
February 08, 2018 09:00 ET
|
Adamas Pharmaceuticals, Inc.
EMERYVILLE, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced that subgroup analyses of Parkinson’s disease patients taking amantadine immediate...
Zero DBS Electrode Infections Reported When Utilizing the ClearPoint® NeuroNavigation System in an MRI Suite
April 20, 2016 09:00 ET
|
ClearPoint Neuro, Inc.
IRVINE, Calif., April 20, 2016 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today announced the results of a 10 year study in which Deep Brain Stimulation (DBS) leads were implanted in...
MRI Interventions Reports 2014 Financial Results
March 05, 2015 16:00 ET
|
ClearPoint Neuro, Inc.
IRVINE, Calif., March 5, 2015 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), a commercial stage medical device company focused on creating innovative platforms for performing the next...
Mazor Robotics Renaissance(R) Guidance System Helping Patients with OCD
March 05, 2015 06:10 ET
|
Mazor Robotics
ORLANDO, Fla., March 5, 2015 (GLOBE NEWSWIRE) -- Mazor Robotics (www.mazorrobotics.com), a global leader in the development and distribution of innovative surgical guidance systems for spine and brain...
MRI Interventions Exhibiting Its Advanced Neurosurgical Navigation Platform, the ClearPoint Neuro Intervention System, at AANS 2013 Annual Meeting
April 29, 2013 08:00 ET
|
ClearPoint Neuro, Inc.
NEW ORLEANS, April 29, 2013 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today announced that its ClearPoint® Neuro Intervention System is on exhibit at the 2013 Annual Meeting of the...